JP2016054696A - 細胞培養方法 - Google Patents
細胞培養方法 Download PDFInfo
- Publication number
- JP2016054696A JP2016054696A JP2014184700A JP2014184700A JP2016054696A JP 2016054696 A JP2016054696 A JP 2016054696A JP 2014184700 A JP2014184700 A JP 2014184700A JP 2014184700 A JP2014184700 A JP 2014184700A JP 2016054696 A JP2016054696 A JP 2016054696A
- Authority
- JP
- Japan
- Prior art keywords
- cell
- protein
- cells
- culture method
- cell culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004113 cell culture Methods 0.000 title claims abstract description 42
- 210000004027 cell Anatomy 0.000 claims abstract description 160
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 132
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 130
- 239000002245 particle Substances 0.000 claims abstract description 93
- 238000000034 method Methods 0.000 claims abstract description 32
- 239000003960 organic solvent Substances 0.000 claims abstract description 27
- 239000007864 aqueous solution Substances 0.000 claims abstract description 26
- 239000012528 membrane Substances 0.000 claims abstract description 24
- 238000005406 washing Methods 0.000 claims abstract description 4
- 210000003494 hepatocyte Anatomy 0.000 claims description 32
- 108010035532 Collagen Proteins 0.000 claims description 15
- 102000008186 Collagen Human genes 0.000 claims description 15
- 229920001436 collagen Polymers 0.000 claims description 15
- 238000012258 culturing Methods 0.000 claims description 15
- 239000011148 porous material Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 238000004132 cross linking Methods 0.000 claims description 9
- 230000004956 cell adhesive effect Effects 0.000 claims description 8
- 239000003431 cross linking reagent Substances 0.000 claims description 8
- 238000012136 culture method Methods 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 6
- 150000002148 esters Chemical group 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 238000010899 nucleation Methods 0.000 claims description 5
- 210000000130 stem cell Anatomy 0.000 claims description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 108010085895 Laminin Proteins 0.000 claims description 4
- 102000007547 Laminin Human genes 0.000 claims description 4
- 108060008539 Transglutaminase Proteins 0.000 claims description 4
- 229920000729 poly(L-lysine) polymer Polymers 0.000 claims description 4
- 102000003601 transglutaminase Human genes 0.000 claims description 4
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 claims description 3
- 102000016942 Elastin Human genes 0.000 claims description 3
- 108010014258 Elastin Proteins 0.000 claims description 3
- 239000001263 FEMA 3042 Substances 0.000 claims description 3
- 108010067306 Fibronectins Proteins 0.000 claims description 3
- 102000016359 Fibronectins Human genes 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 claims description 3
- 241000124008 Mammalia Species 0.000 claims description 3
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 3
- 102100037369 Nidogen-1 Human genes 0.000 claims description 3
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 3
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 3
- 102000007000 Tenascin Human genes 0.000 claims description 3
- 108010008125 Tenascin Proteins 0.000 claims description 3
- 108010031318 Vitronectin Proteins 0.000 claims description 3
- 102100035140 Vitronectin Human genes 0.000 claims description 3
- 235000011054 acetic acid Nutrition 0.000 claims description 3
- 229920002549 elastin Polymers 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 claims description 3
- 230000002440 hepatic effect Effects 0.000 claims description 3
- 210000003897 hepatic stem cell Anatomy 0.000 claims description 3
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 3
- 108010008217 nidogen Proteins 0.000 claims description 3
- 229920002866 paraformaldehyde Polymers 0.000 claims description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019260 propionic acid Nutrition 0.000 claims description 3
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims description 3
- 229920002258 tannic acid Polymers 0.000 claims description 3
- 229940033123 tannic acid Drugs 0.000 claims description 3
- 235000015523 tannic acid Nutrition 0.000 claims description 3
- 230000001464 adherent effect Effects 0.000 claims description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 2
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract description 23
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract description 23
- 210000002744 extracellular matrix Anatomy 0.000 abstract description 22
- 230000008611 intercellular interaction Effects 0.000 abstract description 15
- 230000008602 contraction Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 230000006870 function Effects 0.000 description 19
- 238000005054 agglomeration Methods 0.000 description 18
- 230000002776 aggregation Effects 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 18
- 230000003993 interaction Effects 0.000 description 14
- 239000003814 drug Substances 0.000 description 8
- 230000014509 gene expression Effects 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 102000009027 Albumins Human genes 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 6
- 102000007981 Ornithine carbamoyltransferase Human genes 0.000 description 6
- 101710198224 Ornithine carbamoyltransferase, mitochondrial Proteins 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 230000001172 regenerating effect Effects 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 230000021164 cell adhesion Effects 0.000 description 5
- 230000036267 drug metabolism Effects 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000003915 cell function Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000007876 drug discovery Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000017 hydrogel Substances 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002073 fluorescence micrograph Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000001000 micrograph Methods 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 239000012460 protein solution Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 108010082117 matrigel Proteins 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 238000012835 hanging drop method Methods 0.000 description 1
- 210000004024 hepatic stellate cell Anatomy 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000002032 lab-on-a-chip Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000001178 neural stem cell Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- CIBMHJPPKCXONB-UHFFFAOYSA-N propane-2,2-diol Chemical compound CC(C)(O)O CIBMHJPPKCXONB-UHFFFAOYSA-N 0.000 description 1
- -1 propionic acid carboxylic acid Chemical class 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 238000002723 toxicity assay Methods 0.000 description 1
- 230000002463 transducing effect Effects 0.000 description 1
- 230000004143 urea cycle Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014184700A JP2016054696A (ja) | 2014-09-10 | 2014-09-10 | 細胞培養方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014184700A JP2016054696A (ja) | 2014-09-10 | 2014-09-10 | 細胞培養方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016054696A true JP2016054696A (ja) | 2016-04-21 |
| JP2016054696A5 JP2016054696A5 (enExample) | 2017-10-12 |
Family
ID=55756228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014184700A Pending JP2016054696A (ja) | 2014-09-10 | 2014-09-10 | 細胞培養方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2016054696A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114574431A (zh) * | 2022-04-01 | 2022-06-03 | 赛百思科技有限公司 | 一种类器官或球状体的培养方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05293360A (ja) * | 1992-04-15 | 1993-11-09 | Nippon Oil & Fats Co Ltd | リポソームの製造方法 |
| JP2010530293A (ja) * | 2007-05-21 | 2010-09-09 | フイルメニツヒ ソシエテ アノニム | 大きいコアセルベート化カプセル |
| JP2012172028A (ja) * | 2011-02-19 | 2012-09-10 | Chiba Univ | 球形あるいは非球形ポリマー粒子の合成方法 |
| JP2014051435A (ja) * | 2012-09-04 | 2014-03-20 | Kyushu Univ | 新規イオン液体およびその用途 |
-
2014
- 2014-09-10 JP JP2014184700A patent/JP2016054696A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05293360A (ja) * | 1992-04-15 | 1993-11-09 | Nippon Oil & Fats Co Ltd | リポソームの製造方法 |
| JP2010530293A (ja) * | 2007-05-21 | 2010-09-09 | フイルメニツヒ ソシエテ アノニム | 大きいコアセルベート化カプセル |
| JP2012172028A (ja) * | 2011-02-19 | 2012-09-10 | Chiba Univ | 球形あるいは非球形ポリマー粒子の合成方法 |
| JP2014051435A (ja) * | 2012-09-04 | 2014-03-20 | Kyushu Univ | 新規イオン液体およびその用途 |
Non-Patent Citations (1)
| Title |
|---|
| 化学工学会秋季大会研究発表講演要旨集 (2012) VOL.44, XA1P56, JPN6018024616 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114574431A (zh) * | 2022-04-01 | 2022-06-03 | 赛百思科技有限公司 | 一种类器官或球状体的培养方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jensen et al. | Is it time to start transitioning from 2D to 3D cell culture? | |
| Lin et al. | Recent advances in three‐dimensional multicellular spheroid culture for biomedical research | |
| Kilic et al. | Brain-on-a-chip model enables analysis of human neuronal differentiation and chemotaxis | |
| Zheng et al. | Precise control of cell adhesion by combination of surface chemistry and soft lithography | |
| Lee et al. | 3D liver models on a microplatform: well-defined culture, engineering of liver tissue and liver-on-a-chip | |
| Tsuda et al. | Monodisperse cell-encapsulating peptide microgel beads for 3D cell culture | |
| Peerani et al. | Enabling stem cell therapies through synthetic stem cell–niche engineering | |
| Satpathy et al. | Developments with 3D bioprinting for novel drug discovery | |
| Jafari et al. | Remote control in formation of 3D multicellular assemblies using magnetic forces | |
| CA2684544A1 (en) | Improved three-dimensional biocompatible skeleton structure containing nanoparticles | |
| US8435787B2 (en) | Alginate polyelectrolyte encapsulation of embryonic stem cells | |
| Peng et al. | Challenges in bio-fabrication of organoid cultures | |
| Park et al. | Fabrication of cell spheroids for 3D cell culture and biomedical applications | |
| Kim et al. | Fabrication of spheroids with uniform size by self-assembly of a micro-scaled cell sheet (μCS): the effect of cell contraction on spheroid formation | |
| Ahmed | Biomaterial-based in vitro 3D modeling of glioblastoma multiforme | |
| WO2016021498A1 (ja) | 繊維状タンパク質材料の作製方法、および細胞培養方法 | |
| Nair et al. | High density of aligned nanowire treated with polydopamine for efficient gene silencing by siRNA according to cell membrane perturbation | |
| Jaklenec et al. | High throughput layer-by-layer films for extracting film forming parameters and modulating film interactions with cells | |
| Yang et al. | Engineered liver tissue in vitro to mimic liver functions and its biomedical applications | |
| Onbas et al. | Fabrication of tunable 3D cellular structures in high volume using magnetic levitation guided assembly | |
| JP2017526378A (ja) | ３次元細胞培養システム及びこれを用いた細胞培養方法 | |
| Hori et al. | One-step formation of microporous hydrogel sponges encapsulating living cells by utilizing bicontinuous dispersion of aqueous polymer solutions | |
| Otsuka | Nanofabrication technologies to control cell and tissue function in three-dimension | |
| Sun et al. | Functional stem cell sorting via integrative droplet synchronization | |
| Kim et al. | Three‐dimensional patterning of the ECM microenvironment using magnetic nanoparticle self assembly |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170831 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170831 |
|
| RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7425 Effective date: 20170913 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180629 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180629 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20181220 |